等待開盤 07-17 09:30:00 美东时间
0.000
0.00%
Autolus Therapeutics授予60名员工总计360,550股股票期权,行使价为$2.47,期权有效期为10年,分四年归属,第一年归属25%,剩余部分每月归属,需员工持续服务。公司简介:Autolus是一家早期商业化阶段的生物制药公司,利用T细胞编程技术开发下一代T细胞疗法,用于治疗癌症和自身免疫疾病,已有已上市疗法AUCATZYL,并有多款候选产品在研。
07-15 20:05
An update from D4t4 Solutions ( ($GB:CLBS) ) is now available. Celebrus Technol...
07-08 20:43
An update from D4t4 Solutions ( ($GB:CLBS) ) is now available. Celebrus Technol...
04-22 15:32
Kai Korschelt, an analyst from Canaccord Genuity, maintained the Buy rating on ...
2024-12-03 18:25
D4t4 Solutions (GB:CLBS) has released an update. Celebrus Technologies announce...
2024-10-28 23:02
D4t4 Solutions (GB:CLBS) has released an update. D4t4 Solutions PLC has reporte...
2024-08-29 18:21
D4t4 Solutions (GB:CLBS) has released an update. Celebrus Technologies PLC anno...
2024-08-08 17:29
D4t4 Solutions (GB:CLBS) has released an update. Celebrus Technologies plc has ...
2024-08-08 15:20
D4t4 Solutions (GB:CLBS) has released an update. D4t4 Solutions PLC has announc...
2024-06-11 23:19
D4t4 Solutions (GB:CLBS) has released an update. Ennismore Fund Management Limi...
2024-06-07 22:49